Vaccine News and Research

Latest Vaccine News and Research

Nemours receives NIH grant to foster COVID-19 vaccine uptake among children in Black and Latino communities

Researchers at Nemours Children's Hospital, Delaware, as part of a public-private partnership, have received a National Institutes of Health grant supplement through the Delaware Clinical and Translational Research ACCEL Program to develop and test an approach to foster uptake of the COVID-19 vaccine among children in Black and Latino communities.

27 Sep 2021

Enterovirus 71 vaccine candidate strains exhibit good immunogenicity and cross-neutralization activity

Announcing a new article publication for Zoonoses journal. In this commentary researchers from Beijing Minhai Biotechnology Co., Ltd., Beijing, China, Hubei Provincial Center for Disease Control and Prevention, Wuhan, China, Guangdong Provincial Institute of Biological Products and Drugs, Guangzhou, China, Gaozhou Center for Disease Control and Prevention, Guangdong, China and the Yangchun Center for Disease Control and Prevention, Guangdong, China consider immungenicity and cross-neutralizing activity of enterovirus 71 vaccine candidate strains.

27 Sep 2021

An in-depth assessment into origin and spread of SARS-CoV-2 Delta variant in Brazil

Brazilian researchers characterize the dissemination of the Delta VOC in Brazil and assess its emergence within the global Delta phylogeny.

27 Sep 2021

Third COVID-19 mRNA vaccine booster dose indicated for myelofibrosis patients

A new study discusses the utility of a third booster dose in patients with myelofibrosis.

27 Sep 2021

Chronic COVID-19 and divergent variants of SARS-CoV-2

A new study discusses the isolation of two variants of concern (VOCs) from an immunocompromised COVID-19 patient.

27 Sep 2021

Trial of Sanofi/GSK SARS-CoV-2 vaccine boosters against variants in non-human primates

New research discusses the development of soluble prefusion-stabilized spike trimers (CoV2 preS dTM) comprising adjuvant AS03.

27 Sep 2021

A new SARS-CoV-2 variant (B.1.1.523) capable of escaping immune protections

A new study describes a new variant that possesses a novel combination of various concerning mutations at the spike region.

27 Sep 2021

NYU wins roughly $4 million federal grant to protect transit workers from COVID-19

NYU School of Global Public Health researchers have been awarded a five-year, roughly $4 million grant from the National Institutes of Health to study efforts to protect New York City transit workers from COVID-19 and how these infection prevention and control programs impact the health and well-being of frontline workers.

27 Sep 2021

Characterization of SARS-CoV-2 infections diagnosed after mRNA BNT162b2 vaccination

A team from the National Institute for Infectious Diseases “L. Spallanzani” (INMI) has recently reported their study on 94 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections (47.9% symptomatic, 52.1% asymptomatic) that occurred after the first or second vaccine dose against SARS-CoV-2 in the Lazio region (Central Italy).

27 Sep 2021

Who qualifies for a covid booster? The list is growing longer

On Friday, Centers for Disease Control and Prevention Director Rochelle Walensky said people whose jobs put them at risk of coronavirus infection qualify for a shot to boost the protection of their covid-19 vaccination.

27 Sep 2021

These schools use weekly testing to keep kids in class — and covid out

On a recent Monday morning, a group of preschoolers filed into the gymnasium at Hillside School in the west Chicago suburbs. These 4- and 5-year-olds were the first of more than 200 students to get tested for the coronavirus that day — and every Monday — for the foreseeable future.

27 Sep 2021

Firefighters on front lines, no strangers to risk, push back against covid vaccine mandates

Kentucky firefighter Jimmy Adams saw the ravages of the coronavirus pandemic when he served as a medic who helped care for the sick on medical calls amid surging covid cases.

27 Sep 2021

SARS-CoV-2 entry inhibitors show antiviral activity

A new study used a combination of a computer-aided drug design approach and cell-based in vitro assays to identify five potential SARS-CoV-2 inhibitors.

27 Sep 2021

Design of peptide vaccine for SARS-CoV-2

In a recent study, researchers from the US identified two immunogenic non-structural proteins - PLpro and RdRp - from immunodominant gene regions ORF1ab, ORF3a and ORF9b as potential targets for a vaccine against SARS-CoV-2.

27 Sep 2021

Study suggests two doses of COVID-19 vaccine may offer some protection for kidney transplant patients

Researchers from Toronto, Canada, performed a cohort study to analyze the impact of COVID-19 vaccination on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and clinical outcomes in kidney transplant patients. This study is available on the preprint server, medRxiv.

27 Sep 2021

mRNA COVID vaccines prove effective in the elderly

Coronavirus disease 2019 (COVID-19) proved extremely difficult to control once it entered a country – while there were a few success stories such as New Zealand, most countries ended up resorting to lengthy and economically painful lockdowns, among other restriction measures.

27 Sep 2021

IAVG reviews various challenges to enhance Covid-19 vaccine access

The Independent Allocation Vaccine Group (IAVG) was established by the WHO in January 2021 and is composed of 12 members who serve in their personal, independent capacities to review and assess Vaccine Allocation Decision (VAD) proposals generated by the COVAX Facility Joint Allocation Taskforce (JAT) on the volumes of vaccines that should be allocated to each participant under COVAX within a given time frame.

27 Sep 2021

Study shows prior COVID-19 and vaccination protects elderly against variants

In order to qualify the risk posed to the elderly, researchers from MUSE University in France began to investigate data from nursing homes that had faced outbreaks from variants of concern. Their work can be found on the medRxiv* preprint server while awaiting peer review.

27 Sep 2021

Global leaders underline their commitment to ensure equitable access to COVID-19 vaccines

Global leaders attending the Global COVID-19 Summit hosted by the United States have again underlined their commitment to ensuring equitable access to COVID-19 vaccines for all countries through COVAX – noting that equitable access is essential to end the acute stage of the pandemic.

27 Sep 2021

WHO emphasizes the necessity to address acute health needs in Afghanistan

We recently completed a high level mission to Kabul, Afghanistan, where we met with senior members of the Taliban leadership, UN partners, health care workers and patients, and WHO staff.

27 Sep 2021

Vaccine News and Research

Latest Vaccine News and Research

Nemours receives NIH grant to foster COVID-19 vaccine uptake among children in Black and Latino communities

Enterovirus 71 vaccine candidate strains exhibit good immunogenicity and cross-neutralization activity

An in-depth assessment into origin and spread of SARS-CoV-2 Delta variant in Brazil

Third COVID-19 mRNA vaccine booster dose indicated for myelofibrosis patients

Chronic COVID-19 and divergent variants of SARS-CoV-2

Trial of Sanofi/GSK SARS-CoV-2 vaccine boosters against variants in non-human primates

A new SARS-CoV-2 variant (B.1.1.523) capable of escaping immune protections

NYU wins roughly $4 million federal grant to protect transit workers from COVID-19

Characterization of SARS-CoV-2 infections diagnosed after mRNA BNT162b2 vaccination

Who qualifies for a covid booster? The list is growing longer

These schools use weekly testing to keep kids in class — and covid out

Firefighters on front lines, no strangers to risk, push back against covid vaccine mandates

SARS-CoV-2 entry inhibitors show antiviral activity

Design of peptide vaccine for SARS-CoV-2

Study suggests two doses of COVID-19 vaccine may offer some protection for kidney transplant patients

mRNA COVID vaccines prove effective in the elderly

IAVG reviews various challenges to enhance Covid-19 vaccine access

Study shows prior COVID-19 and vaccination protects elderly against variants

Global leaders underline their commitment to ensure equitable access to COVID-19 vaccines

WHO emphasizes the necessity to address acute health needs in Afghanistan

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Newsletters you may be interested in